| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 4,512 | 2,180 | 726 | | Cost of Revenue | 4,432 | 2,091 | 642 | | | Gross Profit | 80 | 89 | 85 | | | Operating Expenses | | Research Development | 1,072 | 321 | 155 | | Selling General and Administrative | 11,662 | 11,319 | 3,114 | | Non Recurring |
-
|
-
|
-
| | Others | 546 | 374 | 148 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (13,199) | (11,925) | (3,332) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 459 | 285 | 6 | | Earnings Before Interest And Taxes | (12,740) | (11,640) | (3,326) | | Interest Expense | 9 | 38 | 58 | | Income Before Tax | (12,749) | (11,678) | (3,384) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,749) | (11,678) | (3,384) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (12,749) | (11,678) | (3,384) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,749) | ($11,678) | ($3,384) |
|
0.01% Nasdaq 
0.22%
Income Statement
